Erik Greb July 20, 2021 The antiplatelet medication dipyridamole reduces motor and sensory symptoms of restless legs syndrome (RLS) and improves sleep duration for treatment-naive patients, results of a small, randomized, placebo-controlled trial show. After 2 weeks of treatment, scores on the International Restless Legs Rating Scale (IRLS) decreased by 13 points for patients who received dipyridamole, compared with 5 points among those...
KECK SCHOOL OF MEDICINE OF USC IMAGE: IMAGES OF CELLS SHOWING CLOSE PROXIMITY (YELLOW) OF GRP78 (GREEN) WITH SPIKE PROTEIN OF SARS-COV-2 (RED) (LEFT PANELS) AND ACE2 (RED) (RIGHT PANELS). CREDIT: LEAD AUTHOR ANTHONY CARLOS, PHD The swift development of vaccines has provided a vital tool to combat the spread of the deadly SARS-CoV-2 virus,...
by Georgia Institute of Technology This groundbreaking research is driven by the need for a better thrombolytic agent – a safer, more efficient treatment for breaking down blood clots in the immediate wake of a catastrophic event. Credit: Georgia Institute of Technology In a fortuitous case of mistaken chemical identity, a team of Georgia Tech bioengineers has discovered...
by Melanoma Institute Australia Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0 In what is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy, a new study has revealed that drug treatment before surgery is effective in preventing...
Researchers from Karolinska Institutet and Gothenburg University have investigated a potential new drug target for the rare genetic disorder Hutchinson-Gilford progeria syndrome that causes accelerated aging in children. The findings in mice are published in the scientific journal eLife and may aid in the development of more effective treatments for this fatal condition. Hutchinson-Gilford progeria syndrome,...
by University of Washington Fatma Inanici applies small patches that will deliver electrical currents to the injured area on a participant’s neck. Note: This photo was taken in 2018. Credit: Marcus Donner/Center for Neurotechnology Almost 18,000 Americans experience traumatic spinal cord injuries every year. Many of these people are unable to use their hands and arms...
BRIGHAM AND WOMEN’S HOSPITAL Patients suffering from irritable bowel syndrome with constipation (IBS-C) have long needed an upgrade in treatment. Rapid-release, cramp-inducing doses of chenodeoxycholic acid (CDC) have previously shown promise in treating constipation, but further development has been hampered by the abdominal pain associated with the sudden release of CDC. Researchers at Brigham and Women’s Hospital...
As many as 75 percent of the women in North American experience hot flashes, and many of these women still look to hormone therapy to relieve the surge of hormones, otherwise known as vasomotor symptoms, or VMS. But new research, shared recently at the Annual North American Menopause Society Conference, shows the direction of VMS therapy is turning toward new...
Cedars-Sinai research published in the New England Journal of Medicine supports FDA approval of drug for thyroid eye disease CEDARS-SINAI MEDICAL CENTER LOS ANGELES (Feb. 9, 2020) — Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life,...
